Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2006 [see all tables in this series...]

Part (ii) Inpatient treatment centres

Country		Males			Females			Total
		Mean age at first use	Mean age at entering treatment	Time lag between first use and first treatment demand	Mean age at first use	Mean age at entering treatment	Time lag between first use and first treatment demand	Mean age at first use	Mean age at entering treatment	Time lag between first use and first treatment demand
Opioids		22.2	29.7	7.5	22.0	28.5	6.5	22.2	29.5	7.3
Cocaine		22.7	31.7	9.0	21.2	29.3	8.1	22.5	31.3	8.8
Stimulants		19.5	26.9	7.4	18.3	24.7	6.4	19.1	26.2	7.1
Hallucinogens		18.5	23.5	5.0	17.5	22.5	5.0	18.5	23.4	4.9
Hypnotics and sedatives		27.1	33.6	6.5	33.4	38.0	4.6	29.9	36.2	6.3
Cannabis		18.9	27.4	8.5	17.2	23.6	6.4	18.7	26.9	8.2
Volatile inhalants		15.7	19.4	3.7	15.1	18.1	3.0	15.7	19.3	3.6
Other substances		24.3	30.9	6.6	28.0	32.9	4.9	25.8	31.5	5.7

Notes:

 Only countries supplying data are reported 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — Inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)